Polycystic ovary syndrome (PCOS), one of the most common endocrine disorders affecting women
on reproductive age , seems to be associated with an increased incidence of cardiovascular
disease. At present, insulin-sensitizing drugs, such as metformin, represent one of the most
important line treatment for hyperinsulinemic PCOS women. Metformin is able to produce
favourable outcomes on the metabolic derangements in insulin-resistant normal weight and
obese PCOS patients. Oral contraceptives represent the traditional medical therapy for the
long-term treatment of PCOS women, in order to obtain regular menstrual cycles and to
improve the clinical signs of hyperandrogenism.Based on the above mentioned evidences, the
aim of the present study was to evaluate the effects of DRPS/EE alone versus metformin alone
versus DRPS/EE plus metformin on the CD4+CD28null T cells frequency and on
endocrino-metabolic parameters, in hyperinsulinemic PCOS patients
Interventional
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment
CD4+CD28null frequency
five minutes
Yes
Italy: National Institute of Health
disfunzionale14
NCT01581814
October 2008
March 2012
Name | Location |
---|